Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.91 +0.01 (+0.09%)
At close: Nov 13, 2026 · 4:00 PM EST

Drugs Made In America Acquisition (DMAA) Long-Term Debt Repayments (2024 - 2025)

Updated

Drugs Made In America Acquisition (DMAA) posted Long-Term Debt Repayments of $900,000 for FY2025, down 30.8% from $1.3 million in FY2024.

Analysis

Drugs Made In America Acquisition (DMAA) Long-Term Debt Repayments (2024 - 2025) Analysis & Trends

  • Business Quant data shows DMAA's Long-Term Debt Repayments at $1.3 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 BlackRock 189.07 Bn 145.60 Bn - -
2 Spdr Gold Trust 125.11 Bn -432.90 Bn - -
3 Brookfield 101.47 Bn -96.66 Bn - -
4 Blackstone 91.35 Bn 85.56 Bn - 599.84 Mn
5 Kkr 87.89 Bn 54.59 Bn 1.76 Bn 3.96 Bn
6 Brookfield Asset Management 82.34 Bn 77.22 Bn - 100.00 Mn
7 Apollo Global Management 72.94 Bn 89.74 Bn 4.14 Bn 1.48 Bn
8 Wheaton Precious Metals 59.70 Bn 59.70 Bn 538.50 Mn -372.00 Mn
9 Ares Management 48.49 Bn 47.07 Bn 376.28 Mn 766.55 Mn
10 Drugs Made In America Acquisition 336.16 Mn 336.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 900,000.00
Dec 31, 2024 2.50 Mn
Sep 30, 2024 1.20 Mn
API Access

Drugs Made In America Acquisition Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=DMAA&period=max&api_key=YOUR_API_KEY